A. Karaoglu Et Al. , "Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1, pp.63-66, 2009
Karaoglu, A. Et Al. 2009. Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1 , 63-66.
Karaoglu, A., Arslan, U. Y., ÖZKAN, M., Kalender, M. E., Alici, S., Coskun, U., ... Gumus, M.(2009). Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1, 63-66.
Karaoglu, Aziz Et Al. "Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1, 63-66, 2009
Karaoglu, Aziz Et Al. "Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1, pp.63-66, 2009
Karaoglu, A. Et Al. (2009) . "Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1, pp.63-66.
@article{article, author={Aziz Karaoglu Et Al. }, title={Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2009, pages={63-66} }